—

Kiniksa Pharmaceuticals Ltd(KNSA)— 同業公司組

數據截至2026-10-29 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Kiniksa Pharmaceuticals Ltd的Closelook綜合評分為57/100,在同業公司組內排名第4位(共7家)——組內評分最高的是Laboratorios Farmaceuticos ROVI(62/100)。

名稱綜合動能品質估值訊號距52週高點
KNSA Kiniksa Pharmaceuticals Ltd57975918ok0.8%
ROVI.MC Laboratorios Farmaceuticos ROVI62347750info27.8%
LNTH Lantheus Holdings Inc60727454ok10.3%
BHC.TO Bausch Health Companies Inc58927182info1.9%
GALDY GALDERMA GROUP AG57706022info1.6%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56935846ok1.5%
IRWD Ironwood Pharmaceuticals Inc56317783warn37.4%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-29

Quick answers

Kiniksa Pharmaceuticals Ltd在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Ironwood Pharmaceuticals Inc (IRWD)。

KNSA相對同業公司的評分如何?

Kiniksa Pharmaceuticals Ltd的綜合評分為57/100,組內排名第4位(共7家),截至2026-10-29;組內最高綜合評分為Laboratorios Farmaceuticos ROVI(62/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.